Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3237438 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Plasmodium falciparum N-myristoyltransferase in Plasmodium berghei [GtoPdb: 2955] | ||||||||
GtoPdb | Parasite liver stage assay | - | 6.43 | pEC50 | 372 | nM | EC50 | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
Plasmodium falciparum N-myristoyltransferase in Plasmodium falciparum K1 [GtoPdb: 2955] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 6.47 | pEC50 | 339 | nM | EC50 | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
Plasmodium falciparum N-myristoyltransferase in Plasmodium falciparum NF54 [GtoPdb: 2955] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 6.63 | pEC50 | 232 | nM | EC50 | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
Plasmodium falciparum N-myristoyltransferase/Glycylpeptide N-tetradecanoyltransferase in Plasmodium falciparum 3D7 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2169722] [GtoPdb: 2955] [UniProtKB: Q8ILW6] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum N-myristoyltransferase by CPM fluorescence assay | B | 8.1 | pKi | 8 | nM | Ki | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
GtoPdb | Enzyme inhibition assay | - | 8.1 | pKi | 8 | nM | Ki | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
ChEMBL | Inhibition of Plasmodium falciparum N-myristoyltransferase by CPM fluorescence assay | B | 7.77 | pIC50 | 17 | nM | IC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
GtoPdb | Parasite growth inhibition assay | - | 6.52 | pEC50 | 302 | nM | EC50 | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
Plasmodium falciparum N-myristoyltransferase in Plasmodium falciparum Dd2 [GtoPdb: 2955] | ||||||||
GtoPdb | Parasite growth inhibition assay | - | 6.04 | pEC50 | 916 | nM | EC50 | J Med Chem (2014) 57: 2773-88 [PMID:24641010] |
Plasmodium berghei (target type: ORGANISM) [ChEMBL: CHEMBL612653] | ||||||||
ChEMBL | Antimicrobial activity against Plasmodium berghei sporozoites infected in 12 hrs compound pretreated human HepG2 cells assessed as reduction in viability of exoerythrocytic forms measured after 48 hrs of incubation by luciferase bioluminescence assay | F | 6.43 | pEC50 | 372 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimicrobial activity against blood-stage Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting | F | 6.04 | pEC50 | 916 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
ChEMBL | Antimicrobial activity against blood-stage Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting | F | 6.47 | pEC50 | 339 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
ChEMBL | Antimicrobial activity against late stage trophozoite form of Plasmodium falciparum 3D7 infected in RBCs after 48 hrs by SYBR green viability assay | F | 6.52 | pEC50 | 302 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
ChEMBL | Antimicrobial activity against blood-stage Plasmodium falciparum 3D7 assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting | F | 6.52 | pEC50 | 302 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
ChEMBL | Antimicrobial activity against blood-stage Plasmodium falciparum NF54 assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting | F | 6.63 | pEC50 | 232 | nM | EC50 | J Med Chem (2014) 57: 2773-2788 [PMID:24641010] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]